DocGo Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- DocGo Inc. payments for repurchase of common stock for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- DocGo Inc. payments for repurchase of common stock for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- DocGo Inc. payments for repurchase of common stock for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- DocGo Inc. payments for repurchase of common stock for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- DocGo Inc. payments for repurchase of common stock for fiscal 2025 was $10.83M, a 21.28% decline from fiscal 2024.
- DocGo Inc. payments for repurchase of common stock for fiscal 2024 was $13.76M.
- DocGo Inc. payments for repurchase of common stock for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- DocGo Inc. payments for repurchase of common stock for fiscal 2022 was $3.73M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $0.00 derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $5.08M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $10.83M 10-K · filed 2026-03-16 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $13.51M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $5.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $14.80M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $5.75M 10-Q · filed 2026-05-11 | $14.63M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $13.76M 10-K · filed 2026-03-16 |
| 2024-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $11.08M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $9.78M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $4.88M 10-Q · filed 2025-05-08 | $4.88M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 10-K · filed 2026-03-16 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.23M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $3.23M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.73M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$140.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | |
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |